Search for: "NEXUS PHARMACEUTICALS, INC."
Results 1 - 20
of 58
Sorted by Relevance
|
Sort by Date
11 Dec 2017, 7:39 am
" Plexxikon Inc. v. [read post]
3 Nov 2022, 7:35 am
In Nexus Pharmaceuticals, Inc. v. [read post]
6 Jan 2011, 8:30 pm
By Jason Rantanen In re Glatt Air Techniques, Inc. [read post]
11 Nov 2011, 3:04 pm
By way of background, Amgen, Inc. [read post]
22 Aug 2017, 5:00 am
Shareholders asserted there was a sufficient nexus between the sales of tobacco products and the death of customers to create a significant policy issue for the company. [read post]
15 Feb 2017, 6:26 am
The case is Physicians Healthsource, Inc. v. [read post]
27 Sep 2020, 6:36 pm
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
26 Apr 2021, 3:32 am
Gilead Sciences, Inc. v. [read post]
16 Aug 2021, 2:37 pm
Prods., Inc. v. [read post]
9 Feb 2017, 6:14 pm
By William Kolarik The New Jersey Tax Court’s opinion in Elan Pharmaceuticals, Inc. v. [read post]
16 May 2022, 12:16 pm
Nexus Requirement for Secondary Considerations: Zaxcom, Inc. v. [read post]
19 Dec 2022, 4:00 pm
Background Akebia Therapeutics, Inc. [read post]
5 Oct 2020, 10:25 am
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
17 May 2011, 10:37 pm
Endo Pharmaceuticals appealed three applications related to time-released opioids. [read post]
29 Aug 2011, 8:17 am
IMS Health Inc., — U.S. [read post]
17 Feb 2021, 3:28 pm
Hikma Pharmaceuticals USA Inc. [read post]
5 Apr 2023, 5:18 am
This is provided that there is a sufficiently direct causal nexus between the patent infringement and those losses, and the losses are not regarded as too remote to be recoverable. [read post]
2 Dec 2011, 2:00 pm
Qualitest Pharmaceuticals Inc., 2011 WL 334671, at *3 (E.D. [read post]
26 Aug 2009, 5:14 pm
Ortho-McNeil Pharmaceutical v. [read post]
23 Aug 2012, 12:47 pm
Qualitest Pharmaceuticals, Inc., C.A. [read post]
